Critical Cybersecurity Vulnerabilities in Contec and Epsimed Patient Monitors

Severity: High (Score: 72.0)

Sources: digital.nhs.uk, www.fda.gov

Summary

The FDA and CISA have issued advisories regarding significant cybersecurity vulnerabilities in Contec CMS8000 and Epsimed MN-120 patient monitors. These devices are at risk due to a backdoor in their firmware, which allows unauthorized access and potential manipulation of patient data. The vulnerabilities include remote code execution and data exfiltration to a hard-coded public IP address. Affected organizations are urged to implement mitigations as these vulnerabilities could lead to severe breaches of patient confidentiality. Currently, there are no reported incidents of exploitation, but the potential for abuse remains high. The FDA has mandated that affected devices be used only for local monitoring, eliminating their internet connectivity. The vulnerabilities could affect a wide range of healthcare facilities using these monitors. CISA has recommended reviewing their advisory for further guidance. Key Points: • Contec CMS8000 and Epsimed MN-120 patient monitors have critical vulnerabilities. • A backdoor in the firmware allows unauthorized access and data exfiltration. • The FDA has restricted the devices to local monitoring only, removing internet capabilities.

Key Entities

• Data Breach (attack_type)
• Malware (attack_type)
• Comtec (company)
• Contec Health (company)
• Cybersecurity and Infrastructure Security Agency (company)
• Epsimed (company)
• Food And Drug Administration (company)
• United States (country)
• CWE-200 - Exposure of Sensitive Information (cwe)
• CWE-287 - Improper Authentication (cwe)
• Cwe-787 - Out-of-bounds Write (cwe)
• Healthcare (industry)
• T1041 - Exfiltration Over C2 Channel (mitre_attack)
• T1071 - Application Layer Protocol (mitre_attack)
• T1547 - Boot Or Logon Autostart Execution (mitre_attack)
• T1567 - Exfiltration Over Web Service (mitre_attack)
• Contec Cms8000 (platform)
• Epsimed Mn-120 (platform)